3 results
Will not start
Analyze the protective effect of intranasal corticosteroids against exercise induced upper and lower airway obstruction
Approved WMOCompleted
Efficacy and safety during 24 treatment weeks.
Approved WMOPending
PrimaryTo demonstrate the superiority of galcanezumab versus placebo in the prevention of migraine in an adolescent population (12 to 17 year-olds) with chronic migraineSecondary* To compare galcanezumab with placebo with respect to 50% response…